Emkay Global Financial is bullish on Samvardhana Motherson International has recommended buy rating on the stock with a target price of Rs 94 in its research report dated December 04, 2022.
Posts tagged MC
Buy Samvardhana Motherson International; target of Rs 94: Emkay Global Financial (05-12-2022)
Buy ICICI Bank; target of Rs 1225: Emkay Global Financial (05-12-2022)
Emkay Global Financial is bullish on ICICI Bank has recommended buy rating on the stock with a target price of Rs 1225 in its research report dated December 04, 2022.
Buy Aditya Birla Fashion; target of Rs 380: Motilal Oswal (05-12-2022)
Motilal Oswal is bullish on Aditya Birla Fashion recommended buy rating on the stock with a target price of Rs 380 in its research report dated December 04, 2022.
Buy ICICI Bank; target of Rs 1150: Motilal Oswal (05-12-2022)
Motilal Oswal is bullish on ICICI Bank recommended buy rating on the stock with a target price of Rs 1150 in its research report dated December 04, 2022.
Buy ICICI Bank; target of Rs 1150: Motilal Oswal (05-12-2022)
Motilal Oswal is bullish on ICICI Bank recommended buy rating on the stock with a target price of Rs 1150 in its research report dated December 04, 2022.
Buy Sheela Foam; target of Rs 3300: ICICI Direct (05-12-2022)
ICICI Direct is bullish on Sheela Foam recommended buy rating on the stock with a target price of Rs 3300 in its research report dated December 03, 2022.
Buy ICICI Bank; target of Rs 1090: Prabhudas Lilladher (05-12-2022)
Prabhudas Lilladher is bullish on ICICI Bank has recommended buy rating on the stock with a target price of Rs 1090 in its research report dated December 04, 2022.
Buy Polycab India; target of Rs 3215: Sharekhan (05-12-2022)
Sharekhan is bullish on Polycab India has recommended buy rating on the stock with a target price of Rs 3215 in its research report dated December 02, 2022.
Buy Natco Pharma; target of Rs 704: Geojit (05-12-2022)
Geojit is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 704 in its research report dated December 05, 2022.
Vijaya Diagnostics: Stabilisation in pricing adds to constructive take (05-12-2022)
We see Vijaya DIagnostics as a good proxy for regional health-care services consumption play